Effect of intensive therapy for heart failure on the vasodilator response to exercise

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 743-749

  Johnson, Wendy ^a   Lucas, Caroline ^a   Stevenson, Lynne W ^a   Creager, Mark A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIURETIC AGENT; HYDRALAZINE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMAN; HYPEREMIA; ISCHEMIA; LEG BLOOD FLOW; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION; VASOMOTOR REFLEX;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATION;

EID: 0033101516     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00631-7     Document Type: Article

References (54)

1. Jondeau G, Katz SD, Toussaint JF, et al. Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacity. J Am Coll Cardiol 1993;22:1399-402.
2. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993;21:641-8.
3. Aversano T, Ouyang P, Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 1991;69: 618-22.
4. Kilbom A, Wennmalm A. Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia. J Physiol (Lond) 1976; 257:109-21.
5. Katz SD, Biasucci L, Sabba D, et al. Impaired endotheliummediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.
6. Kubo SH, Rector TH, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96.
7. Lindsay DC, Holdright DR, Clarke D, Anand IS, Poole-Wilson PA, Collins P. Endothelial control of lower limb blood flow in chronic heart failure. Heart 1996;75:469-76.
8. Meredith IT, Creager SJ, Scales KM, Creager MA. Normal endothelium-dependent but abnormal endothelium-independent vasodilation in patients with idiopathic-dilated cardiomyopathy (Abstract). Circulation 1993;88:I-20.
9. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-70.
10. Arnold JM, Ribeiro JP, Colucci WS. Muscle blood flow during forearm exercise in patients with severe heart failure. Circulation 1990;82:465-72.
11. Hayoz D, Drexler H, Munzel T, et al. Flow-mediated arterial dilation is abnormal in congestive heart failure. Circulation 1993;87:VII-92-96.
12. Higgins CB, Vatner SF, Franklin D, Braunwald E. Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs. Circ Res 1972;31:186-94.
13. Hirai T, Zelis R, Musch TI. Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure. Cardiovasc Res 1995;30:469-76.
14. Katz SD, Krum H, Khan T, Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 1996;28:585-90.
15. Nakamura M, Chiba M, Ueshima K, et al. Impaired cholinergic peripheral vasodilation and its relationship to hyperemic calf blood flow response and exercise intolerance in patients with chronic heart failure. Int J Cardiol 1995;48:139-46.
16. Wang J, Seyedi N, Xu XB, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 1994;266:H670-80.
17. Wilson JR, Wiener DH, Fink LI, Ferraro N. Vasodilatory behavior of skeletal muscle arterioles in patients with nonedematous chronic heart failure. Circulation 1986;74:775-9.
18. Hare DL, Ryan TM, Selig SE, Krum H, Pellizer A, Wrigley TV. Effects of weight training in patients with chronic heart failure [abstract]. Circulation 1996;94:I-192.
19. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996;93:210-4.
20. Sinoway LI, Minotti JP, Davis D, et al. Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation. Am J Cardiol 1988;61:1076-9.
21. Sinoway LI, Minotti J, Musch T, et al. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease. Am J Cardiol 1987;60:107-11.
22. Feigenbaum H. Echocardiography. 5th ed. Philadelphia (PA): Lea & Febiger, 1994:252.
23. Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol 1989;63:461-4.
24. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
25. Maskin CS, Forman R, Sonnenblick EH, Frishman WH, LeJemtel TH. Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. Am J Cardiol 1983;51:177-82.
26. Massie BM, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in patients with congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 1988;78:320-6.
27. Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 1984;53:1308-15.
28. Sinoway LI. The effect of conditioning and deconditioning stimuli on metabolically determined blood flow in humans and implications for congestive heart failure. Am J Cardiol 1988; 62:45E-8E.
29. Minotti JR, Johnson EC, Hudson TL, et al. Training-induced skeletal muscle adaptations are independent of systemic adaptations. J Appl Physiol 1990;68:289-94.
30. Kubo SH, Rector TS, Bank AJ, et al. Effects of cardiac transplantation on endothelium-dependent dilation of the peripheral vasculature in congestive heart failure. Am J Cardiol 1993;71:88-93.
31. Stevenson LW, Steimle AE, Fonarow G, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 1995;25:163-70.
32. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure: exercise perfor-mance, hemodynamics, ventilation, and autonomic function. Circulation 1992;8:2119-31.
33. Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S, Takeshita A. Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation 1994;90:2886-90.
34. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Contribution of endotheliumderived nitric oxide to exercise-induced vasodilation. Circulation 1994;90:2853-8.
35. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9.
36. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in the human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996;270:H1435-40.
37. Meredith IT, Jain RK, Anderson TJ, Ganz P, Creager MA. Endothelium-derived nitric oxide contributes to exercise-induced hyperemia in the human forearm (Abstract). Circulation 1994;90:I-295.
38. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2285-90.
39. Carlsson I, Wennmalm A. Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. Prostaglandins 1983;26:241-52.
40. Kilbom A, Wennmalm A. Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia. J Physiol (Lond) 1976; 257:109-21.
41. Bockman EL, Berne RM, Rubio R. Adenosine and active hyperemia in dog skeletal muscle. Am J Physiol 1976;230: 1531-7.
42. Carlsson I, Sollevi A, Wennmalm A. The role of myogenic relaxation, adenosine, and prostaglandins in human forearm reactive hyperaemia. J Physiol (Lond) 1987;389:147-61.
43. Dobson JG Jr, Rubio R, Berne RM. Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res 1971;29:375-84.
44. Banitt PF, Smits P, Williams SB, Ganz P, Creager MA. Activation of ATP-sensitive potassium channels contributes to reactive hyperemia in humans. Am J Physiol 1996;271: H1594-8.
45. Kanatsuka H, Sekiguchi N, Sato K, et al. Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart. Circ Res 1992;71:912-22.
46. Sinoway LI, Wilson JS, Zelis R, et al. Sympathetic tone affects human limb vascular resistance during a maximal metabolic stimulus. Am J Physiol 1988;255:H937-46.
47. Zelis R, Delea CS, Coleman HN, Mason DT. Arterial sodium content in experimental congestive heart failure. Circulation 1970;41:213-6.
48. Zelis R, Lee G, Mason DT. Influence of experimental edema on metabolically determined blood flow. Circ Res 1974;34: 482-90.
49. Zelis R, Mason DT. Diminished forearm arteriolar dilator capacity produced by mineralocorticoid-induced salt retention in man: implications concerning congestive heart failure and vascular stiffness. Circulation 1970;41:589-92.
50. Mombouli JV, Vanhoutte PM. Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharmacol 1991;18: 926-7.
51. Wiemer G, Scholkens BA, Becker RH, Busse R. Ramaprilat enhances endothelial autocoid formation by inhibiting break-down of endothelium-derived bradykinin. Hypertension 1991; 18:558-63.
52. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
53. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular Superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.
54. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995;26:164-70.